Reduction in Oregon's Medication Dosing Visits After the SARS-CoV-2 Relaxation of Restrictions on Take-home Medication

To slow the spread of SARS-CoV-2 in opioid treatment programs (OTPs), SAMHSA notified State Opioid Treatment Authorities that stable patients could receive up to 27 days of take-homes, less stable patients could receive up to 13 days with fewer take-homes for other patients. An analysis assessed how...

Descripción completa

Detalles Bibliográficos
Autores principales: McIlveen, John W., Hoffman, Kim, Priest, Kelsey C., Choi, Dongseok, Korthuis, Phillip Todd, McCarty, Dennis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339128/
https://www.ncbi.nlm.nih.gov/pubmed/33560697
http://dx.doi.org/10.1097/ADM.0000000000000812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339128/
https://www.ncbi.nlm.nih.gov/pubmed/33560697
http://dx.doi.org/10.1097/ADM.0000000000000812

Ejemplares similares